Global Manufacturing of CAR T Cell Therapy

by Bruce L. Levine, James Miskin, Keith Wonnacott, Christopher Keir
Published 2017-03-01

CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success

by Kristen B. Long, Regina M. Young, Regina M. Young, Alina C. Boesteanu, Megan M. Davis, Megan M. Davis, J. Joseph Melenhorst, J. Joseph Melenhorst, J. Joseph Melenhorst, Simon F. Lacey, Simon F. Lacey, Simon F. Lacey, David A. DeGaramo, Bruce L. Levine, Bruce L. Levine, Joseph A. Fraietta, Joseph A. Fraietta, Joseph A. Fraietta
Published 2018-12-01

Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.

by Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, Jessica L Ullman, William G Telford, Veena Kapoor, James L Riley, Bruce L Levine, Carl H June, Timothy Fong, Noel L Warner, Daniel H Fowler
Published 2010-02-01

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells

by Andrew M. Stein, Stephan A. Grupp, John E. Levine, Theodore W. Laetsch, Michael A. Pulsipher, Michael W. Boyer, Keith J. August, Bruce L. Levine, Lori Tomassian, Sweta Shah, Mimi Leung, Pai‐Hsi Huang, Rakesh Awasthi, Karen Thudium Mueller, Patricia A. Wood, Carl H. June
Published 2019-05-01